1. (a) The board shall submit the initial approved preferred drug list to the office not later than August 1, 2002.
2. (b) Except as permitted under subsection (g), the office may not further restrict the status of a drug in the Medicaid program or the children's health insurance program until the board reviews a therapeutic classification and the office implements the therapeutic classification on the preferred drug list.
3. (c) The office shall provide advance notice to providers of the contents of the preferred drug list submitted by the board under subsection (a).
4. (d) Notwithstanding IC 12-15-13-6 , the office shall implement any change in the preferred drug list not later than thirty (30) days after the date the board submits the amended list to the office.
5. (e) Except as provided by section 28(g)(2) of this chapter, the office may not implement a preferred drug list or an amendment to the preferred drug list that has not been approved by the board.
6. (f) The office may not require prior authorization for a drug that is excluded from the preferred drug list unless the board has made the determinations required under section 35 of this chapter.
7. (g) The office may adopt rules under IC 4-22-2 necessary to carry out this chapter.

As added by P.L.107-2002, SEC.19. Amended by P.L.184-2003, SEC.8; P.L.23-2026, SEC.87.